Toft Group Names COO
March 22, 2018 – Given the integration of technology into all facets of everyday life, the healthcare industry is hardly alone in facing technology-related issues. But these take on increased importance when they impact health, disease diagnosis, treatment and, ultimately, human longevity.
Having the right leaders, especially those with vision and transformational skills, to sort through such complex challenges, say recruiters serving the sector, is critical.
So it is that the search industry has recently seen firms that specialize in healthcare showing signs of growth. The latest: Toft Group Executive Search has appointed Ronald Giannotti as its chief operating officer. He will oversee the firm’s corporate development, client care, marketing and sales teams and lead the San Francisco branch.
“Demand for top talent, particularly qualified diverse candidates, is at an all-time high as healthcare companies recognize a talent gap has emerged, driven by waves of baby-boomer retirements,” said Robin Toft, founder, president and CEO. “Ron is a proven leader with an extensive track record of building successful healthcare companies. His strategic leadership and deep network will be instrumental as we help clients navigate through this talent crisis and continue to find the best job candidates quickly.”
Healthcare Veteran
Mr. Giannotti has more than 35 years of healthcare sales, marketing and executive leadership experience, with a particular focus on medical diagnostic and therapeutic devices. Most recently, he was the president and CEO of Trinity Orthopedics, a company advancing innovative implants and instrumentation for minimally invasive spine surgery. He also founded KFx Medical, which focused on the design and manufacture of soft-tissue fixation implants for orthopedic sports surgeons.
Related: Shifting Needs in Life Sciences Attract Non-Traditional Talent
Prior to that, he was vice president of global marketing and sales for Guidant Corp. (now Boston Scientific), overseeing the cardiac and vascular surgery division; VP of marketing and sales at EndoVascular Technologies, until its acquisition by Guidant Corporation; VP of global marketing in the Edwards Critical Care division at Baxter International; and national sales manager in the Edwards Heart Valve Division at Baxter International.
Life Sciences Recruiters Turning More Often to Outside Talent
As the life sciences sector continues to expand and reshape itself, organizations in the field are looking to renew and refresh their leadership ranks. In demand: multi-skilled executives who can effect change on many levels. These new captains of industry, according to recruiters, are younger, more intuitive and understand that what works today might not be what’s going to work tomorrow. Stepping up to the task are search consultants, recruiting well-rounded individuals who understand science as well as the dynamics of a transitioning industry. Here’s some further reading from Hunt Scanlon Media.
ESR Healthcare & Life Sciences Recruiting Special Issue
This issue of Hunt Scanlon Media’s ESR is devoted to finding leaders for life sciences and healthcare organizations. Given the massive transformation occurring in these two sectors, everything in this issue likely applies to you. You’ll also find our first-ever Top 50 list of recruiters dedicated to this space.
“Toft Group’s ability to find top-notch talent for executive positions in healthcare, including highly qualified diverse candidates, is unparalleled,” said Mr. Giannotti. “I look forward to applying my experience in the medical device and health-tech industry to build upon the firm’s established success and further grow the company.”
Related: Leadership Void: Change Agents Sought for Life Sciences Sector
With offices in San Francisco, San Diego and Boston, Toft Group Executive Search specializes in searches for organizations in biotech, pharmaceutical, medical device and diagnostics. The firm recently filled senior-level roles for Fate Therapeutics, Agendia, OPKO Health, NanoString Technologies and Mesa Biotech.
Related: Life Sciences Specialist Expands to Pharmaceutical Capital
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; Stephen Sawicki, Managing Editor; and Will Schatz, Managing Editor – Hunt Scanlon Media
